SurGenTec was granted U.S. Patent No. 9,655,748, Bone Graft Delivery System and Method for Using Same, pertaining to the GRAFTGUN® delivery system that is slated for launch this summer.
GRAFTGUN supports delivery of synthetic, allograft or autograft material in a minimally invasive fashion, and includes a loading device and multiple tube sizes with embedded radiopaque markers. Ratcheting technology provides the force necessary to extrude most bone grafts.
SurGenTec was granted U.S. Patent No. 9,655,748, Bone Graft Delivery System and Method for Using Same, pertaining to the GRAFTGUN® delivery system that is slated for launch this summer.
GRAFTGUN supports delivery of synthetic, allograft or autograft material in a minimally invasive fashion, and includes a loading device and multiple tube sizes...
SurGenTec was granted U.S. Patent No. 9,655,748, Bone Graft Delivery System and Method for Using Same, pertaining to the GRAFTGUN® delivery system that is slated for launch this summer.
GRAFTGUN supports delivery of synthetic, allograft or autograft material in a minimally invasive fashion, and includes a loading device and multiple tube sizes with embedded radiopaque markers. Ratcheting technology provides the force necessary to extrude most bone grafts.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





